Recognition of modified histone species by distinct structural domains within 'reader' proteins plays a critical role in the regulation of gene expression. Readers that simultaneously recognize histones with multiple marks allow transduction of complex chromatin modification patterns into specific biological outcomes. Here we report that chromatin regulator tripartite motif-containing 24 (TRIM24) functions in humans as a reader of dual histone marks by means of tandem plant homeodomain (PHD) and bromodomain (Bromo) regions. The three-dimensional structure of the PHD-Bromo region of TRIM24 revealed a single functional unit for combinatorial recognition of unmodified H3K4 (that is, histone H3 unmodified at lysine 4, H3K4me0) and acetylated H3K23 (histone H3 acetylated at lysine 23, H3K23ac) within the same histone tail. TRIM24 binds chromatin and oestrogen receptor to activate oestrogen-dependent genes associated with cellular proliferation and tumour development. Aberrant expression of TRIM24 negatively correlates with survival of breast cancer patients. The PHD-Bromo of TRIM24 provides a structural rationale for chromatin activation through a non-canonical histone signature, establishing a new route by which chromatin readers may influence cancer pathogenesis.
Post-translational modifications of histones occur in combinations that must be faithfully translated by effector proteins, or histone readers [1] [2] [3] [4] . The lexicon of histone modifications may be highly context-dependent, influenced by inductive signalling, cellular milieu and target gene status 4 . Misinterpretation or imbalance in this hierarchal arrangement has dire consequences for cellular homeostasis, leading to developmental problems, hereditary disease or tumour development 5 . Linked histone reader modules, such as tandem PHD finger and bromodomain, occur frequently in proteins that interact with histone, but little is known about their mechanisms of action. Combinatorial readout of histone posttranslational modifications (PTMs) may enhance binding between spatially separated histone marks, or even create communication links between domains or members of the complex 3 . Individually, proteins with bromodomains-for example, TAF1 and BDF1-associate with acetylated lysines with broad specificity 6, 7 , while PHD-containing proteins are less predictable in their interactions [1] [2] [3] [4] . The PHD fingers of BHC80 and AIRE interact with unmethylated H3K4 (H3K4me0) 8, 9 , while other previously reported PHD finger domains bind methylated proteins as modifiers of histones or as subunits of chromatinremodelling, co-activator or co-repressor complexes [1] [2] [3] [4] [10] [11] [12] [13] [14] [15] [16] [17] .
PHD-finger proteins and their dysregulation are linked to a broad spectrum of human diseases, underscoring an essential role in homeostasis 5 . Recently, aberrant localization of a JARID1A PHD fingerfusion protein was shown as directly causal in transformation and development of haematopoietic malignancy, which is a process requiring fusion protein recognition of H3K4me3 via the JARID1A PHD finger 18 . Here, we present evidence that a multi-functional protein, TRIM24, which is an E3-ubiquitin ligase that targets p53 (ref. 19 ) and is broadly associated with chromatin silencing 20 , relies on PHD-Bromo to recognize specific, combinatorial histone modifications and activate oestrogen-dependent genes associated with cellular proliferation and tumour development. Genome-wide analysis of chromatin interactions shows oestrogen-dependent binding of TRIM24 and oestrogen receptor a (ERa) at sites that paradoxically exhibit oestrogen-activated loss of H3K4me2 and gain of histone acetylation. Importantly, aberrant overexpression of TRIM24 in breast cancer patients is frequent and directly correlated with poor survival.
TRIM24 PHD-Bromo binds amino-terminal H3 tail TRIM24 belongs to the TRIM/RBCC protein family, characterized by a conserved, N-terminal tripartite motif-namely, a RING domain, B-box zinc-fingers, and a coiled-coil region-as well as variable carboxyterminal domains 21, 22 . TRIM24 was originally identified as transcriptional intermediary factor (TIF) 1a, a ligand-dependent, co-repressor of retinoic acid receptor that interacts with multiple nuclear receptors in vitro via an LXXLL motif 23 . In addition to its LXXLL motif and RING domain, TRIM24 has a C-terminal, PHD-Bromo ( Fig. 1a) , which probably recognizes histones or non-histone proteins with specific combinations of post-translational modifications.
Protein sequence alignment of the PHD fingers of TRIM24 and BHC80 with ING1, a PHD domain that recognizes H3K4me3 (refs 24,25) , showed TRIM24 as highly similar to BHC80 with conservation of residues critical for BHC80-H3K4me0 interactions 8 ( Supplementary Fig. 1a ). Accordingly, we found that full-length TRIM24 interacts with histone proteins specifically through its PHD-Bromo ( Supplementary Fig. 1b ). Binding of the TRIM24 PHD-Bromo to histone peptide arrays occurs at unmodified H3 (residues 1-21), methylated H3K9 (H3K9me) and acetylated H3K9/K14 peptides, but not methylated H3K4 residues ( Supplementary Fig. 1c ). Similarly, TRIM24 PHD finger and PHD-Bromo bind unmodified histone H3 (residues 1-21) but not methylated H3K4, similar to BHC80 but unlike ING1, which preferentially binds to H3K4me peptides ( Fig. 1b and Supplementary Fig. 1d ). Glutathione S-transferase (GST)-pulldown assays with native histones confirmed that TRIM24 PHD finger, bromodomain, PHD-Bromo and the BHC80 PHD fail to bind to native histone H3 with K4 trimethylation (H3K4me3) but tolerate H3K9me2 modification ( Fig. 1c and Supplementary Fig. 1e ). Isothermal titration calorimetry (ITC)-based binding assays established that the PHD-Bromo binds unmodified H3(1-15)K4 with a dissociation constant, K D , of 8.6 mM, while methylation of H3K4 greatly decreases binding affinity of TRIM24 and H3 peptides ( Fig. 1d and Supplementary Table 2 ). These results suggest that TRIM24 PHD-Bromo interacts with the N-terminal tail of histone H3, but that specific PTMs, for example, methylation of H3K4, interfere with this interaction.
Structural basis of H3 readout by TRIM24
We have determined the three-dimensional crystal structure of the PHD-linker-Bromo segment (residues 824-1006) of human TRIM24 in free and histone peptide bound states. The overall structure of TRIM24 PHD-Bromo in the free state demonstrates that PHD and bromodomain interact extensively and form an integrated structural unit (747 Å 2 of contact surface), connected by a long linker and stabilized by a network of hydrogen bonding and hydrophobic interactions ( Fig. 2a , Supplementary Fig. 2 , Supplementary Table 1 ). The TRIM24 PHD finger residues 824-871 adopt the typical PHD finger 'cross-braced' topology stabilized by a pair of coordinated zinc ions, which together with residues 872-884 from the linker region form an extended TRIM24 PHD domain. The TRIM24 bromodomain adopts the typical left-handed four-helical bundle characteristic of other members of this family.
The 2.0 Å co-crystal structure of TRIM24 PHD-Bromo and unmodified H3(1-10)K4 peptide (Supplementary Table 1 and Supplementary  Fig. 3a ) showed that the first nine residues of bound H3 peptide are positioned within a surface groove of the PHD finger ( Fig. 2b and Supplementary Fig. 3b ). The R2 to Q5 segment of bound H3 peptide forms an anti-parallel b-sheet with the E837 to C840 segment of the PHD finger, while the T6 to K9 segment of bound H3 peptide contacts the N834 to G836 segment of the PHD finger. The side chain of R2 is hydrogen-bonded with the backbone carbonyl of C841. The side chain of C840 is positioned in-between the side chains of R2 and K4, with the C840W mutation losing its ability to bind unmodified H3K4 peptide (K D . 400 mM, Supplementary Table 2 and Supplementary Fig. 4 ) .
The unmodified lysine ammonium group of H3K4 forms two direct hydrogen bonds with backbone carbonyl oxygens of N825 and E826 (Fig. 2b ). In addition, the proximally positioned D827 forms a stabilizing salt bridge with the unmodified lysine, consistent with the observation of impaired binding between D827A mutant and unmodified H3K4 peptide (K D 5 133 mM, Supplementary Table 2 ). Methylation of H3K4 would create steric clashes with residues lining the binding pocket, disrupt the salt bridge interaction with D827, and impair hydrogen bonding with N825 and E826, thereby providing a structural explanation for the unmodified H3K4 preference of TRIM24 PHD-Bromo.
TRIM24 bromodomain is H3K23ac-specific
Both sequence and structure-based alignments indicate that TRIM24 bromodomain is an acetyllysine reader. Peptide pulldown assays and NMR titration measurements suggest that TRIM24 bromodomain interacts with H3 peptides with K23 or K27 acetylation and several acetylated H4 peptides ( Supplementary Fig. 5a, b ). ITC studies establish that TRIM24 PHD-Bromo specifically binds to the H3(13-32)K23ac peptide with a value of K D (8.8 mM; Supplementary Table 2 ) comparable to tetra-acetylated H4 peptide and double bromodomain modules of TAF1 or BDF1.
We solved the 1.9 Å crystal structure of the complex of TRIM24 PHD-Bromo and H3(13-32)K23ac peptide (Supplementary Table 1 and Supplementary Fig. 6a ). Residues 23-27 of the bound H3(13-32)K23ac peptide exhibit sequence-specific interactions with TRIM24 bromodomain ( Fig. 2c and Supplementary Fig. 6b ). The acetyllysine side chain forms a direct hydrogen bond with the side chain of conserved N980. Acetyllysine recognition constitutes the binding determinant, as double mutant F979A/N980A loses most of the binding affinity for the H3(13-32)K23ac peptide (Supplementary Table 2 
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bond between the side chains of K27ac and N980, while other histone residues did not show any direct intermolecular contacts with the bromodomain ( Supplementary Fig. 7 ), consistent with weak binding affinity of H3(13-32)K27ac peptide. The structure of TRIM24 PHD-Bromo bound to H4(14-19)K16ac peptide containing the conserved interaction between K16ac and N980 side chains is shown in Supplementary Fig. 8 . The structures of TRIM24 PHD-Bromo complexes with acetyllysinecontaining histone peptides show that acetyllysine invariantly inserts into a pre-formed acetyllysine-binding pocket of the bromodomain. With the acetyllysine as an anchor, flanking residues determine sequence specificity of acetyllysine peptides for the TRIM24 bromodomain. The H3(13-32)K23ac peptide both fits better within the cleft between ZA and BC loops, and shows sequence-specific interactions with TRIM24 bromodomain spanning K23ac to K27, creating much higher affinity for the TRIM24 bromodomain than is shown by other acetyllysine-containing peptides.
Combinatorial readout by TRIM24 PHD-Bromo
Superimposition of the above structures of complexes revealed that H3K4 and H3K23ac peptides are aligned in the same direction on the surface of the TRIM24 PHD-Bromo (Fig. 2d ). The distance between the Ca of H3K9 and the Ca of H3K23ac is 25.5 Å , which allows one H3 peptide containing both unmodified H3K4 and H3K23ac to simultaneously target the PHD and bromodomain binding sites on TRIM24 PHD-Bromo.
By contrast, H3K4 and H3K27ac (or H4K16ac) peptides are aligned in opposite directions on the surface of TRIM24 PHD-Bromo ( Supplementary Fig. 9 ), which indicates that the TRIM24 PHD-Bromo requires two histone tails, either within a single nucleosome or from an adjacent pair of nucleosomes, to simultaneously bind H3K4 and H3K27ac (or H4K16ac).
To test the effect of combinatorial readout of TRIM24 PHD-Bromo on histone H3 bearing unmodified K4 and acetylated K23 dual marks, we synthesized longer H3(1-33) peptides bearing both unmodified K4 and acetylated K23 marks. For controls, we used H3(1-33)K4me3K23ac, as well as H3(1-33)K4 peptides that have only one effective histone mark for specific TRIM24 PHD-Bromo recognition. On the basis of ITC binding assays, TRIM24 PHD-Bromo showed an approximately 90-fold higher binding affinity for H3(1-33)K4K23ac peptide ( Fig. 2e , K D 5 0.096 mM) compared to the shorter H3(1-15)K4 peptide bearing only unmodified K4 (K D 5 8.6 mM) or for the H3(13-32)K23ac peptide 
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bearing only acetylated K23 marks (K D 5 8.8 mM). Without acetylation on K23, the binding for H3(1-33)K4 is 24-fold weaker ( Fig. 2e ; K D 5 2.3 mM); when K4 is tri-methylated, the binding for H3(1-33)K4me3K23ac is sixfold weaker ( Fig. 2e ; K D 5 0.56 mM). Similarly, mutants that disrupt either the PHD finger binding pocket (C840W) or the bromodomain binding pocket (F979A/N980A) also decreased binding for H3(1-33)K4K23ac peptide by 6-7 fold ( Fig. 2e and Supplementary Table 2 ). On the basis of fluorescence polarization (FP)-based measurement, wild-type TRIM24 PHD-Bromo also showed strong binding affinity for H3(1-33)K4K23ac peptide (K D 5 0.185 mM); peptides trimethylated at K4 or without acetylation at K23 displayed 13-23 fold weaker interaction ( Fig. 2f and Supplementary Table 3 ). Mutation on the PHD finger binding pocket (C840W) or the bromodomain binding pocket (F979A/N980A) showed similar decrease in binding affinities ( Fig. 2f and Supplementary Table 3 ). These binding data strongly support our structural results, which indicate that unmodified H3K4 and acetylated H3K23 are a pair of natural histone marks targeted by TRIM24 PHD-Bromo that can be read in a combinatorial manner on a single histone peptide. This combinatorial readout can greatly increase the recruitment of TRIM24 to nucleosomes bearing these two marks.
TRIM24 and ERa recruitment to chromatin
Combinatorial histone modifications of unmethylated H3K4 alongside acetylated lysines have no straightforward interpretation by the models of chromatin modification and regulated activation or repression of transcription. We considered a model where TRIM24 regulates gene expression by specific binding to chromatin with non-canonical combinations of PTMs, and focused on co-regulation of ERa. This was because in vitro interactions between TRIM24 and nuclear receptors, including ERa, are ligand-dependent ( Supplementary Fig. 10 and ref. 26) , and because ligand-activated, ER-response elements (EREs) are notably independent of H3K4me2 and H3K4me3 modifications 27, 28 . We used chromatin immunoprecipitation (ChIP) and sequential ChIP analyses of ERa-positive, MCF7 breast cancer cells to assess whether TRIM24 is recruited with ERa to specific EREs of the GREB1, PR and pS2/TFF1 genes ( Fig. 3a, b , and Supplementary Fig. 11 ). Oestrogenactivated recruitment occurs robustly within 15 min, and by six hours yields a sevenfold increase of ERa binding and a sixfold increase of TRIM24 binding at the GREB1 distal ERE, ,40 kilobases (kb) upstream of the transcription start site ( Fig. 3a ). ChIP analysis of H3K4me2/3 after oestrogen treatment indicates that quantified H3K4me2 and H3K4me3 levels decreased at distal ERE sites ( Supplementary Fig. 12 and ref. 27 ) and, when normalized for nucleosomal occupancy, decreased or was unchanged at distal EREs ( Fig. 3c and Supplementary Fig. 13 ). Importantly, TRIM24 is recruited in the absence of changes in H3K4 methylation. In contrast, H3K23ac, H3K27ac and H4ac, which are targeted by the TRIM24 bromodomain, are enriched at both distal and proximal EREs after oestrogen-addition (Fig. 3d) . These findings suggest that TRIM24 interacts with ERa and chromatin lacking H3K4 methylation but enriched in lysine acetylation, as suggested by our structural analyses, in response to oestrogen.
These findings stand in contrast to a model of chromatin accessibility at ER binding sites, facilitated by FOXA1 and H3K4me2 enrichment in response to oestrogen treatment 29 , but are in agreement with findings that H3K4me3 is not present at a majority of distal ERE regions 28 . We evaluated global chromatin-association of TRIM24, ERa and H3K4me2, by ChIP and deep sequencing of antibody-enriched DNA fragments (ChIP-seq). These analyses revealed binding of TRIM24 and ER at more than 10,000 sites genome-wide; half of which, in each case, are oestrogen-dependent ( Fig. 3e and Supplementary Fig. 14a ). Shared target sites of ERa and co-regulator TRIM24 increase dramatically (eightfold) in response to oestrogen ( Supplementary Fig. 14b ), are highly enriched (P value ,0.001) at genes regulated by oestrogen 30 ( Supplementary Fig. 14c ), and function in cell cycle, kinase activity and signal transduction (DAVID analyses 31 , Supplementary Table 4 ). Biological pathway analysis (Ingenuity Systems, www.ingenuity.com) revealed that multiple gene targets of TRIM24 are associated with breast cancer ( Supplementary Tables 5 and 6 ). The number of target sites shared by TRIM24 and ERa (1,677 sites) is similar to ERa and FOXA1 (ref. 29) , with little overlap among all three (263 sites) ( Supplementary Fig. 14b ). Consistent with our structural analyses, TRIM24 binding occurs globally at sites depleted of H3K4me2 ( Fig. 3f and Supplementary Figs 14d and 15 ). Thus, ERa-regulated genes may be divided into multiple classes, defined by specific coregulators and their dependence on H3K4 methylation.
TRIM24 is overexpressed in breast cancer
Depletion of TRIM24 caused a significant decrease in ERa-mediated activation of GREB1, PR and pS2 gene expression ( Fig. 4a and Supplementary Fig. 16a ). Importantly, re-introduction of wild type (WT), but not PHD finger mutant (C840W), TRIM24 fully restored ERamediated transcription activation (Fig. 4b) , and enabled ERa-response at lower levels of hormone (Fig. 4c ). Decreased ERa-mediated activation is due to loss of TRIM24-dependent ERa-interactions with chromatin ( Fig. 4d and Supplementary Fig. 17 ), without alternation of ERa expression ( Supplementary Fig. 16b ). H3K4me2/3 levels at the distal ERE of GREB1 lack hormone responsiveness and are TRIM24-independent RESEARCH ARTICLE ( Fig. 4d and Supplementary Fig. 16c ). In contrast, nucleosomal occupancy at EREs is increased alongside decreased acetylation of H4, H3K23 and H3K27, reflecting loss of ERa-activated chromatin structure ( Fig. 4d and Supplementary Fig. 16c ). Depletion of TRIM24 led to reduced survival and proliferation of tumour-derived breast cancer cells, and is highly additive with 4-OHtamoxifen, an inhibitor of ERa 32 (Fig. 5a ). We immunostained tissue samples from a breast cancer patient cohort to assess the impact of TRIM24 expression on breast cancer survival (Fig. 5b) . In 128 cases of non-metastatic breast cancer, expression of TRIM24 fell into four classes: N2 and N1, undetectable to low level in few foci (29%); N11, abundant foci with expression in nuclear and cytoplasmic compartments (20%); and N111, abundant foci with high expression in nuclei (51%). Overexpression of TRIM24 (111, 11) is clearly correlated with poor patient survival, independent of ER status ( Fig. 5c and Supplementary Table 7 ).
Discussion
Our identification of the PHD-Bromo as a reader of H3K4me0 and H3K23ac within a single histone tail, or of H3K4me0 and noncontiguous acetylated lysines, suggests that TRIM24 may have multiple roles in chromatin regulation 20 . TRIM24 is a co-activator of ERa at distal EREs, a platform well suited for stable interactions with TRIM24 PHD-Bromo. ERa recruits histone acetyltransferases-for example, CBP/p300, GCN5 and P/CAF (ref. 33)-to acetylate histones. LSD1 (KDM1), a biochemically and structurally characterized demethylase for H3K4me2/1 (refs 34, 35) and an androgen-regulated demethylase of H3K9me (ref. 36 ), is resident 37 or rapidly recruited 27 to EREs where H3K4 remains depleted of methylation even with oestrogen activation (Fig. 3c, Supplementary Fig. 18 and ref. 28 ). These parallel processes establish a combinatorial histone signature with high affinity for TRIM24 binding to chromatin.
Aberrant expression of TRIM24 may promote tumour development and progression by multiple mechanisms of dysfunction. TRIM24 is a potent co-activator of ERa, which is associated with cellular proliferation and neoplasia in breast cells 38, 39 , and a negative regulator of p53 stability 19 . TRIM24 is a target of chromosomal translocations to form oncogenic fusion proteins in acute promyelocytic leukaemia 40 , papillary thyroid carcinoma 41 and myeloproliferative syndrome 42 . Here we have shown that TRIM24 expression is directly correlated with poor patient survival in both ER-positive and ERnegative breast cancer. These results suggest that TRIM24 is a dual 
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domain histone reader with considerable potential as a therapeutic target in multiple cancers.
METHODS SUMMARY
Wild-type and mutant forms of TRIM24 PHD-Bromo were expressed in Escherichia coli and purified to homogeneity. Histone biotinylated peptides or purified histone proteins were incubated with GST-proteins, and bound proteins detected by immunoblotting. All crystals were obtained by the hanging-drop method at 20 uC; structures were solved by the molecular replacement method, and refined with cycled model building and refinement procedures. Histone peptides with or without biotin labelling were used for ITC binding. Fluorescein-labelled peptides were used for fluorescence polarization analysis. Stable short hairpin (sh)Control and shTRIM24 MCF7 cells were maintained with 2.5 mg ml 21 puromycin and, for hormone treatment, were grown in hormone-free media for 96 h before addition of ethanol or 10 nM oestradiol (Sigma) for indicated times. Global expression analyses and calculation of enrichment of shared TRIM24 and ERa binding at oestrogen-regulated genes 30 were determined, and validated by real-time RT-PCR. Surgical specimens of breast cancer from 128 non-metastatic patients were immunostained for TRIM 24 (TRIM24 antibody, Proteintech Group), and scored by subcellular localization, staining intensity, and fraction of positive staining. The overall survival after surgery was plotted by the Kaplan-Meier method 43 . 
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METHODS
Cell culture. MCF7 and HEK293T cells were obtained from ATCC. Stable shControl and shTRIM24 MCF7 cells were maintained with 2.5 mg ml 21 puromycin. For hormone treatment, MCF7 cells were plated under normal growth condition (DMEM with 10% FBS and 13 penicillin/streptomycin). When cell density reached 25% confluence, the media were changed to hormone-free media (phenol red-free DMEM, 10% charcoal dextran-treated FBS) for 96 h. The hormone-deprived MCF7 cells were treated with ethanol or 10 nM oestradiol (Sigma) for indicated times. The TRIM24 shRNA for stable cell line creation was AAGCA GGTGG AACAG GATAT TAAAG TTGC. Biotinylated peptide pulldown assay. Histone biotinylated peptides (1 mg, Millipore) were incubated with GST-proteins (2 mg), in 500 ml NTP buffer (300 mM NaCl, 50 mM Tris-HCl, 0.1% NP-40, pH 7.4) overnight at 4 uC. 20 ml of a 50% slurry of Streptavidin-coated beads (Thermo) were added and incubated for 1 h at 4 uC. The beads were recovered by centrifugation and washed 6 times (10 min at 4 uC) with NTP. The peptide/protein bound beads were resuspended in 33 SDS-PAGE loading buffer, heated for 5 min at 95 uC and separated on 4-12% gradient polyacrylamide gels (Invitrogen). GST-proteins were detected by western blotting analysis with anti-GST antibody (Cell Signaling, dilution 1:1,000).
GST protein pull-down assay, co-IP and transient transfection. GST-proteins (2 mg) were incubated with purified histone proteins (10 mg) in 500 ml NTP overnight at 4 uC. 25 ml of a 50% slurry of GST-beads were added and incubated for 2 h at 4 uC, recovered by centrifugation and washed 4 times (10 min at 4 uC) with NTP. The protein bound beads were separated by SDS-PAGE and subjected to western blotting analysis. Anti-GST (Cell Signaling), anti-TRIM24 (Novus Biological), anti-histone H3 (Abcam), anti-H3K9me2 (Active Motif) and anti-H3K4me3 (Active Motif) antibodies were used in immunoblotting. Ethidium bromide-treated and precleared cell lysate was used for IP with TRIM24 antibody (2.5 ml, Novus Biological) or control rabbit IgG antibody (2.5 ml, Upstate) as previously described 44 . Then anti-ER (F-10, Santa Cruz) and anti-TRIM24 were used in western blotting analysis. Transient transfections were performed as previously described 45 , but with Effectene (Qiagen) used according to manufacturer's directions. Chromatin immunoprecipitation assay (ChIP). ChIP assays were performed as described 45 , with minimal modification. Briefly, treated MCF7 cells were crosslinked with 1% formaldehyde for 15 min. The cross-linking reaction was stopped with 0.125 M glycine. The cross-linked cells were washed with PBS three times and stored at 280 uC before use. The fragmented, precleared chromatin lysate was incubated overnight with specific antibodies: ER (F-10, Santa Cruz), TRIM24 (Novus Biological), histone H3 (Abcam), H3K4me2 (Active Motif), H3K4me3 (Active Motif), H3K23ac (Active Motif), H3K27ac (Active Motif), H4ac (Upstate/Millipore) or normal sheep IgG (Upstate/Millipore). To analyse specific, antibody-and protein-bound DNA, qPCR was conducted in a 7500 FAST ABI instrument. PCR primers were used as described 27, 46 . ChIP-sequencing analysis. Purified ChIP DNA was prepared for sequencing using the Illumina ChIP-Seq sample preparation kit (IP-102-1001, Illumina). Sequencing was performed on an Illumina Genome Analyser II using 36 cycles. Sequences were aligned to human genome release hg18 (ref. 47) using the ELAND software at the default 0 to 2 allowed mismatch setting 48 .
High-quality aligned read data was converted to the BED format and analysed for peaks using the MACS software programs 49 . Peaks showing altered pull-down patterns were mapped to the genome, and a list of candidate genes flanking each peak was generated. Foxa1 (ChIP-Chip) binding regions 29 were obtained from http://research.dfci.harvard.edu/brownlab/datasets/. Overlapping regions were identified if any of two regions share more than 80% of their length with the other region. Venn diagrams were prepared on the basis of that assumption.
To identify possible target genes, a RefSeq data file was downloaded from UCSC genome browser (hg18). Genes within 10 kb of the binding regions were marked as target genes; DAVID 31 was used to assess biological functions of targets, and Ingenuity Pathway Analysis (IPA) software was used to ascertain the pathways that are enriched by these target genes (Ingenuity Systems, www. ingenuity.com). For H3K4me2 signals around the Trim24 binding regions, in the presence or absence of oestrogen, numbers of fragments that overlap each position were counted. The Input signal was calculated by the same procedure and overall H3K4me2 signal values were normalized by Input signal.
For intersection with global expression analyses and calculation of enrichment of shared Trim24 and ER binding at oestrogen-regulated genes 30 , raw CEL files were downloaded from the GEO database. RMA normalization was used with default options (with background correction, quantile normalization, and log transformation) to normalize the intensity of each probeset. The SAM statistical method was used to select differentially expressed genes, based on a q-value of less than 2%. After filtration, a total of 1,887 genes were selected as differentially expressed after oestrogen treatment. Venn diagrams were formed based on the proximity of binding regions to genes within 10 kb of the binding sites. P-values were calculated based on binomial tests. Real time RT-PCR analysis. RNA was isolated at indicated time points using Trizol reagent (Invitrogen) following manufacturer's instructions. cDNA was synthesized using a RT-PCR kit (Invitrogen) according to manufacturer's instructions. Synthesized cDNA was treated with RNaseH before performing PCR reactions. Real time PCR reactions were performed in an Applied Biosystems 7500 Fast Real time PCR instrument. Generally, 10 ml PCR reactions were set up in 96-well plates. The reaction mixtures contain 2 ml diluted cDNA (1:10 dilution), 0.25 ml each of forward and reverse primers (20 mM), 5 ml 23 SYBR Green Mix and 2.5 ml water. PCR primers were used as described 46 .
GraphPad Prism5 software was used for analysis of P-values based on at least two independent experiments in three independent PCR reactions. The two-tailed paired t-test was used to compare the differences between two groups for relative fold. The two-tailed unpaired t-test was used to compare the differences between two groups for actual percentage. P-values ,0.05 were considered statistically significant. Colony formation assay. 500 stable control shRNA depleted or TRIM24 shRNA depleted MCF7 cells were distributed in DMEM with 10% FBS and 13 P/S and then placed in 60 mm 2 plates at 37 uC for 14 days. Colonies were stained by crystal violet 14 days after seeding. Colonies of .50 cells were counted using a dissecting microscope. Each sample was performed in triplicate. Clinical patient samples and immunohistochemistry. We obtained 134 archived blocks containing formalin-fixed, paraffin-embedded infiltrating breast carcinoma from the Department of Pathology, Shanghai East Breast Disease Hospital, China. All of the patients were women with non-metastatic disease who had undergone mastectomy and axillary lymph node dissection between 1988 and 1994. After surgical treatment, the patients were offered adjuvant chemotherapy and/or radiotherapy and hormone therapy, depending on the number of lymph node metastases, status of menopause, and oestrogen and/or progesterone receptor positivity. The clinicopathological characteristics of the study population, including age, tumour size, lymph node status, tumour grade, and oestrogen receptor/progesterone receptor positivity, were obtained from medical records. The stage was assessed by the TNM clinical staging system of the American Joint Committee on Cancer. Patients were followed for 4-72 months, with a median follow-up of 48 months. We have follow-up information from 128 patients. Most of the tissues in this cohort were described previously 43 , and used as approved by the Institutional Review Board.
128 surgical specimens of breast cancer were immunostained for TRIM 24 (TRIM24 antibody, Proteintech Group). Immunoreactivity of the TRIM24 antibody was scored according to the subcellular localization (nuclear and/or cytoplasmic), staining intensity (strong 111, moderate 11, weak 1 and faint or slightly above background), and fraction of positive staining. The mean fraction of positive tumour cells was determined in at least nine areas at 3100 or 3200 magnification. Immunoreactivity scores were as described previously. For example, 0 is no staining; 1 is weak staining; 11 is moderate staining; 111 is strong staining and the values for percentage of positive tumour cells: 0 5 0-0.9%; 1 5 1-10%; 2 5 11-50%; 3 5 51-80%; 4 5 81-100%. Magnification was 3400; at least 200 tumour cells were counted 43 . ER assessment was done in a similar manner.
Data on eligible patients were summarized by use of standard descriptive statistics and frequency tabulation. The overall survival after surgery was plotted by use of the Kaplan-Meier method. The log-rank test was used to analyse differences in survival time. All tests were two-sided and the level of significance was set at 0.05. Histone peptide microarray hybridization. Peptide microarray assays were performed as described 50 . Briefly, biotinylated histone peptides were printed in hexaplicates onto a streptavidin coated slide (ArrayIt) using a VersArray Compact Microarrayer (BioRad). After short blocking with biotin (Sigma), the slides were incubated with the GST-TRIM24 PHD-Bromo in binding buffer (300 mM NaCl, 50 mM Tris-HCl 7.5, 0.1% NP-40, 1 mM PMSF, 20% fetal bovine serum) overnight at 4 uC with gentle agitation. After washing with the same buffer, slides were probed with anti-GST antibody and then fluorescein-conjugated secondary antibody and visualized with a GenePix 4000 scanner (Molecular Devices). Protein preparation. As the long linker (30 residues) between TRIM24 PHD finger and bromodomain was predicted to be a loop, we first expressed PHD finger (824-886) and bromodomain (896-1016) separately, and then checked their interaction by the gel-filtration method. The mixture of PHD finger and bromodomain contained a higher molecular weight peak that corresponded to the complex fraction ( Supplementary Fig. 16 ), which indicates that TRIM24 PHD-Bromo forms a structural unit with direct interactions between the domains. Next, we focused on the expression and crystallization of the TRIM24 PHD-Bromo dual domain. We cloned different lengths of TRIM24 ARTICLE RESEARCH
